The Role Of The ASCVD Risk Calculator in Preventive Cardiology Discuss

Assignment Overview
Goal:

Evaluate, Select, and Report on one CAD RISK ASSESSMENT TOOL

Select:

Problem: Nicholine is an 80-year-old female that presented to her Primary Care Provider with intermittent, bilateral calf pain, mild dyspnea on exertion and Angina that has been going on for the past six months. She reports climbing steps makes it worse, walking makes it worse. She reports that she does not take her weekly walks anymore due to the pain associated with walking. She reports rest makes the pain better. A few weeks ago, she was diagnosed with Peripheral Vascular Disease. Use the above information to answer the following questions:

ORDER  HERE A PLAGIARISM-FREE PAPER HERE

Evaluate:

1. Is this patient at risk for Cardiovascular Artery Disease? Why do you think she is at risk? What are her risk factors? What assessment tool would you recommend as a screening tool for this patient? Why did you pick this tool? Considerations if any for picking the assessment tool? Provide references to support your answer.

Identify tool recommended in the EB article e.g https://medlineplus.gov/lab-tests/heart-disease-risk-assessment/Links to an external site.
Is there another tool/s that can be used to assess this problem? – if so, list alternate evidenced based tools which may be considered
Background of selected tool:
Define or Describe your selected tool
Indications for use/ who needs to be assessed
Rationale for this selection. Why is the tool the best selection for the problem compared to the other (not selected)?
Include Reliability and validity of the use
How is it scored
How are the scores obtained with the tool interpreted and how does the tool provide guidance to the treatment plan and improve patient outcomes. Ex. statin therapy indicated. expected outcomes. Additional therapies to support the prevention of MI, etc.

https://medlineplus.gov/lab-tests/heart-disease-risk-assessment/

The Role Of The ASCVD Risk Calculator in Preventive Cardiology Discuss

Nicholine, an octogenarian, displays symptoms of CAD, such as chest pain, exercise dyspnea, and occasional bilateral leg discomfort. It is easily understood because of her age and symptoms that make her susceptible to CAD. However, this diagnosis is another one that exposes systemic vasculature in the body, chronic PVD, which increases her risk profile. The difficulty faced by patients with poor blood flow in performing everyday activities involving movement due to pain, even though there is an urgent need for a reliable test to appraise the risk of CAD associated with nicotinic acids on clinical presentation coupled with other demographic information. The Role Of The ASCVD Risk Calculator in Preventive Cardiology Discuss

The American Society for Cardiovascular Diseases’ (ASCVD) calculator has been endorsed by the country’s most reputable cardiovascular bodies: the ACC and the AHA (Badawy et al., 2022). This endorsement proves its validity. It was intended to allow people to assess their risks for ASCVD (acute coronary heart failure) over 10 years. These statistics are based on the mortality rate due to coronary issues. This can include fatal or nonfatal strokes or myocardial attacks. During the evaluation procedure, for example, the calculating process considers conditions such as age and blood pressure level, including the absence or presence of diabetes diagnoses. This instrument can be used in primary care settings, including Nicholine because it’s simple and complies with ACC and AHA requirements.

While other choices may exist, such as Reynolds Risk Score, Framingham General CVD Risk Profile, or others, their information about Nicholine’s demography could be more extensive. Therefore, the degree of realism of these options will also be reduced. ASCVD Risk Calculator provides a full assessment of risk and is user-friendly. It’s also simple. This is due in part to its extensive research. The tool offers an improved risk classification method and information that can influence future treatments. The tool can be used to classify many demographics, and the updates are calculated according to the latest findings in research. The Role Of The ASCVD Risk Calculator in Preventive Cardiology Discuss

Using the ASCVD Calculator, doctors can categorize their patients based on scores into low, borderline moderate, and high-risk groups (Lindbohm et al., 2021). These scores, displayed as a percentage, estimate the likelihood of a cardiovascular episode in the next decade. Those with a health profile ranging from high to moderate risk are also recommended statins as a preventative medication. The organization aims to lower LDL levels of cholesterol. This reduces the likelihood of developing cardiovascular diseases. It emphasizes the importance of maintaining blood pressure control, making lifestyle changes, and having regular checkups to improve the outcome of cardiovascular disease and other cardiovascular disorders and the overall health of medical professionals.

ASCVD Risk Calculator is the best way to calculate the cardiovascular risk related to nicotinamide. It is, therefore, an excellent way to classify dangers. Research-backed ideas are also offered for prevention measures. After this, medical professionals could use the technology in their clinical practice to identify individuals at risk, such as those taking choline, and apply targeted treatments to lower the risk of cardiovascular disease in these patients. The quality of their lives and the results they get improve.

ASCVD Risk Calculator brings attention to the development of cardiology and the importance of risk assessments tailored to each patient so that the best decisions regarding their treatment are made (Wong et al., 2022). It goes far beyond the practical. When it comes down to encouraging patient involvement in shared decision-making and maximizing available resources, instruments like the ASCVD Calculator are essential. In light of the increased prevalence and use of value-based models in health systems, it is necessary to have this tool. The ability of clinicians to form collaborative partnerships and promote cardiovascular health by giving their patients tailored risk assessments and knowledge that can be implemented, as well as the ability to put that knowledge into action, is enhanced when they provide patients with tailored information.

Another benefit to incorporating ASCVD risk calculators into electronic medical record systems is workflow improvement. This allows for proactive risk assessment during clinical encounters. Continuous surveillance ensures that the population’s health outcomes are improved while reducing cardiovascular disease’s burden on the healthcare systems. To achieve this, real-time risk assessment is used in the early stages of prevention. In addition to the constant modification of prediction models that use data from electronic health records, it will allow them to adapt to various patient demographics and healthcare contexts.

ASCVD Risk Calculator marks a paradigm shift in preventative cardiology (Belardo et al., 2022)The Role Of The ASCVD Risk Calculator in Preventive Cardiology Discuss. It differs from conventional risk assessment methods in that it delivers individualized insights based on data. Both medical professionals and their patients will be alerted to what lies ahead. Using predictive analytics combined with evidence-based medicine allows medical professionals to identify and reduce heart disease risks early. This will lead to a healthier life for Nicholine and society in general.

ORDER NOW

References

Badawy, M. A. E. M. D., Naing, L., Johar, S., Ong, S., Rahman, H. A., Tengah, D. S. N. A. P., … & Tuah, N. A. A. (2022). Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review. BMC Public Health, 22(1), 1742. https://link.springer.com/article/10.1186/s12889-022-13944-w

Belardo, D., Michos, E. D., Blankstein, R., Blumenthal, R. S., Ferdinand, K. C., Hall, K., … & Gulati, M. (2022). Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic cardiovascular disease: an American society for preventive cardiology clinical practice statement. American Journal of Preventive Cardiology, 10, 100323. https://www.sciencedirect.com/science/article/pii/S2666667722000101

Lindbohm, J. V., Sipilä, P. N., Mars, N., Knüppel, A., Pentti, J., Nyberg, S. T., … & Kivimäki, M. (2021). Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study. The Lancet Digital Health, 3(7), e434-e444. https://www.thelancet.com/journals/landig/article/PIIS2589-7500(21)00079-0/fulltext

Wong, N. D., Budoff, M. J., Ferdinand, K., Graham, I. M., Michos, E. D., Reddy, T., … & Toth, P. P. (2022). Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement. American journal of preventive cardiology, 10, 100335. https://www.sciencedirect.com/science/article/pii/S2666667722000228 The Role Of The ASCVD Risk Calculator in Preventive Cardiology Discuss